Saad Z. Usmani, MD

    Saad Z. Usmani, MD

    Director of Plasma Cell Disorders Program, Director of Clinical Research in Hematologic Malignancies, Levine Cancer Institute
    • Guest Commentary: Rise and Rise Again… Monday, March 1st, 2021

      Here, Amrita Krishnan, MD, Nina Shah, MD, and Saad Usmani, MD, reflect on the significance of the swearing in of Kamala Harris, the daughter of immigrants, as Vice President of the United States. As we all witnessed the inauguration of the first South Asian, African American vice president, the daughter of a cancer researcher, we [...]

    • Pulling Back the Curtain: Saad Z. Usmani, MD Thursday, August 1st, 2019

      In this edition, Saad Z. Usmani, MD, talks about the art of emotional intelligence and trekking to Mount Everest base camp with his patients. Hear more from our interview with Dr. Usmani in Sound Bites.

    • Is MRD Testing Worthwhile in Myeloma? Friday, June 16th, 2017

      With the clinically effective treatment regimens now available for myeloma, more patients can achieve deep and sustained responses. The ability to measure minimal residual disease (MRD) during and after treatment has the potential to help guide treatment decisions and predict patients’ likelihood of relapse, but is MRD monitoring ready to be used in routine clinical [...]